Resource Hub
Connecting pharma professionals with company news, expert insights, and patient-centered resources.
Featured content
From Prescription to Persistence: Sustaining GLP-1 Therapy Over Time
How Mighty, the AI health assistant within MyTherapy’s DTP ecosystem, protects GLP-1 persistence at predictable risk moments.
Smartpatient and Novo Nordisk Set a New Standard for Connected Care for People with Metabolic Diseases in Germany
A new Type 2 diabetes support program from smartpatient and Novo Nordisk expands their shared Direct-to-Patient model across metabolic diseases. Continuous, personalized support designed for where long-term treatment habits are formed.
.jpg)
Smartpatient and Daiichi Sankyo Join Forces to Improve Treatment Adherence in Hypercholesterolemia
MyTherapy now provides dedicated digital support for patients treated with Nustendi®, helping them stay adherent and reduce their cardiovascular risk.
Direct-to-Patient Marketing in Pharma: How DTC Pharma Campaigns Drive Better Treatment Uptake
Smartpatient and ALK Celebrate Three Years Driving Long-Term Allergy Treatment Persistence
Through behavioral science and digital engagement, the partnership supports thousands of allergy patients across Europe stay consistent with allergy immunotherapy and achieve lasting outcomes.
Browse all reports and articles
From Prescription to Persistence: Sustaining GLP-1 Therapy Over Time
How Mighty, the AI health assistant within MyTherapy’s DTP ecosystem, protects GLP-1 persistence at predictable risk moments.
.jpg)
MyTherapy and arztkonsultation Establish Integrated Digital Care Pathway – Launching in Clinical Obesity
Pharma Patient Communication: Building Trust That Drives Outcomes
Webinar: Creating Patient Loyalty Through Integrated Direct-to-Patient Ecosystems
Patient Activation Measure Explained: How to Assess and Improve Patient Readiness
Increasing Preventive Kidney Testing Through Patient Activation on MyTherapy
Smartpatient Wrapped 2025
Smartpatient and Daiichi Sankyo Join Forces to Improve Treatment Adherence in Hypercholesterolemia
MyTherapy now provides dedicated digital support for patients treated with Nustendi®, helping them stay adherent and reduce their cardiovascular risk.
How Pharma Can Overcome Longstanding Barriers to Delivering lmpactful Adherence Support
No items found...